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(From the Institute of Physiology, Faculty of Medical Sciences, University of Buenos Aires)
In 1934 Goldblatt and others discovered that partial con-
striction of the main renal artery produces a marked and
permanent hypertension in the dog. The renal experi-
mental hypertension caused by this or other methods in
laboratory animals is similar in many respects to human
essential hypertension. It is not due to excretory in-
sufficiency of the kidney or to an increase of blood volume
or cardiac output, nor is it produced through a nervous
mechanism. Houssay and Fasciolo (1937a, 1937b) have
shown that renal ischaemia results in hypertension through
a humoral mechanism. The ischaemic kidneys of dogs
with chronic hypertension were grafted into the neck of
normal or nephrectomized dogs. The arterial pressure of
the recipient dog rose from 30 to 80 mm. Hg in 5 to 10
minutes, while grafting a normal kidney had no such effect.
The citrated plasma obtained from the veins of these
ischaemic kidneys produced vasoconstriction when per-
fused through a Lawen-Trendelenburg preparation; normal
plasma had no vasoconstrictor action (Houssay and
Taquini, 1938).
Braun-Menendez and Fasciolo (1939a, 1939b) made the
observation that acute partial. ischaemia of the kidneys.pro-
duced the same effects as chronic ischaemia: (1) if the artery
of a normal kidney grafted into the neck of a dog was con-
stricted a slight but definite increase in blood pressure was
produced; (2) the blood of acutely ischaemic kidneys when
injected intravenously into anaesthetized dogs produced greater
increases in blood pressure than control blood; and (3) it had
a vasoconstrictor action on the Lawen-Trendelenburg prepara-
tion. Braun-Menendez, Fasciolo, Leloir, and Mufnoz (1939)
prepared extracts from the venous blood of these kidneys and
discovered a pressor substance which was named " hypertensin."
They found that this substance could also be prepared in vitro
by incubating at 370 C. blood plasma or serum with renin, a
protein which is present in extracts of kidney (Braun-Menendez,
Fasciolo, Leloir, and Mufioz, 1940a). It was also shown that
renin is secreted by the ischaemic kidney and hypertensin is
formed subsequently in the venous blood.
Our present knowledge on the mechanism of renal hyper-
tension might be summarized as follows: The ischaemic kidney
secretes renin. This protein is an enzyme which acts on a blood
globulin (hypertensinogen) and gives rise to a substance (hyper-
tensin) that has a direct vasoconstrictor action. Another enzyme,
hypertensinase, which destroys hypertensin, is present in blood
and tissues.
Some Properties of Renin.-In 1898 Tigerstedt and Bergman
discovered that kidney extracts contained a pressor substance
-renin. This substance is a protein, probably a globulin,
and is inactivated by heat at 600 C. Its intravenous injectiop
produces in the dog a gradual rise in blood pressure which lasts
10 to 30 minutes, depending on the dose. Consecutive injections
of large doses at short intervals produce each time a smaller
response. This phenomenon is called " tachyphylaxis," and was
originally described by Tigerstedt and Bergman. Renin by itself
is neither vasoconstrictor nor vasopressor; these properties
are due to the hypertensin formed by the action of renin on
:hypertensinogen.
Miethods for the Estimation of Renin.-Two general methods
can be used for the detection and estimation of renin. The
first consists in comparing the rise in blood pressure caused
by the injection of an extract or body fluid containing renin
with that of a stindard solution of renin. The second is
based on the formation of hypertensin when renin is mixed
with hypertensinogen. The hypertensin formed can be tested
for its vasoconstrictor (Page, 1940) or pressor action (Leloir,
Mufioz, Braun-Menendez, and Fasciolo, 1940b). The latter
method (Leloir and others 1940a, 1940b), more reliable, has
been used almost exclusively in our laboratory. This method
is specific for renin, very sensitive, and quantitative within the
limits of a bio-assay method. A unit of renin is the amount
which, incubated for 2 hours at 370 C. with an excess of
hypertensinogen, forms 0.5 unit of hypertensin. Applying
these methods, it has been shown that renin is liberated:
1. By Totally Ischaemic Kidneys.-The re-establishment of
the renal circulation of the kidney in situ after total ischaemia
lasting 2 to 6 hours causes a rise in arterial pressure similar to
that produced by an injection of renin. The venous blood
of these kidneys has pressor and vasoconstrictor properties.
Using the quantitative method of Leloir and his colleagues, it
has been shown (Taquini and Braun-Menendez, 1941) that very
large amounts of renin may be liberated by the kidney under
these conditions.
2. By Ischaemic Kidneys of Hypertensive Dogs.-If the
ischaemic kidney of a hypertensive dog is grafted into the neck
of a normal dog a rise in blood pressure is produced similar to
that produced by the injection of a small amount of renin
(Fasciolo, Houssay, and Taquini, 1938). The venous blood of
these kidneys has vasoconstrictor properties (Fasciolo, Houssay,
and Taquini, 1938). Using the quantitative method of Leloir
and his colleagues, renin was estimated in the renal venous
blood of kidneys transplanted under the skin (Dell'Oro and
Braun-Menendez, to be published). No renin was present in
normal conditions, but after constriction of the renal artery,
and coincident with the increase of blood pressure, variable
amounts of renin (from 0.8 to 1.2 units per 12 c.cm. of plasma)
were found in the renal venous blood and in the femoral blood
of these dogs. All these results justify the conclusion that
the ischaemic kidneys of dogs with experimental hypertension
secrete renin into the blood.
3. By Kidneys in Acute Partial Ischaemia.-It has already
been mentioned that a few minutes after partial constriction of
the renal arteries renin can be detected in the venous blood of
these kidneys.
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Secretion of Renin by the Normal Kidney.-Apart from
ischaemia due to constriction of the renal artery, are there
other conditions which result in the secretion of renin by
the kidney? Huidobro and Braun-Menendez (investigations
to be published) have shown that hypotension due to
haemorrhage or shock- causes the liberation of renin by the
intact kidney of normal anaesthetized dogs. Renin was de-
tected and estimated in the systemic blood of these dogs. The
inference is drawn that the kidney participates in the regulation
of arterial blood pressure. When the blood pressure decreases
the normal kidney secretes renin, which through the formation
of hypertensin tends to the restoration of normal blood pressure.
Renin appears to be a substance which the body uses to main-
tain homeostasis. Collins and Hamilton (1942) and Sapirstein,
Ogden, and Southard (1941) have arrived independently at the
same conclusions.
Formation and Mode of Action of Hypertensin
Enzymatic Action of Renin (Munoz et al., 1940)
The formation of hypertensin in vitro or in vivo is the result
of an enzymatic reaction in which the substrate is a blood
globulin that we have called " hypertensinogen," and the enzyme
is renin. This affirmation is based on the following facts:
(1) Renin is a protein: its activity is destroyed by heating
(600 to 80° C.) and delayed or abolished at low temperatures.
(2) The reaction between renin and hypertensinogen has a
temperature optimum of 370 to 45° C. and a pH optimum
of 7.5 to 8.5. (3) The yield of hypertensin is proportional to
the amount of globulins. (4) If the amount of renin exceeds
the optimum the maximum yield of hypertensin is not surpassed
if 10 to 20 times more renin is used. (5) The time necessary
for obtaining the maximum yield of hypertensin, or, in other
words, the velocity of the reaction, depends on the amount
of renin. (6) Hypertensinogen disappears in the reaction while
renin does not.
This is the evidence which supports our assertion that renin
is an enzyme. As the substrate on which renin acts is a protein,
and the product of reaction is, as we shall see, probably a
polypeptide, it is reasonable to classify renin as a proteolytic
enzyme.
Specificity of Renin
Renin may be defined as the substance contained in kidney
extracts which, when incubated with blood globulins, gives
rise to hypertensin. Extracts of other organs-liver, spleen,
placenta, etc.-do not contain renin. Recently Croxatto and
Croxatto (1941) demonstrated that by the action of pepsin on
hypertensinogen a vasoconstrictor and pressor substance is
formed, the properties of which resemble those of hypertensin.
These results, which have been confirmed by ourselves and
by Helmer and Page (1942), constitute strong indirect evidence
in favour of the enzymatic action of renin.
Renin has been found in human kidneys and in the kidneys
of every mammal which has been investigated-ox, horse, dog,
pig, sheep, goat, rat, rabbit, guinea-pig, etc. The incubation
of renin from these animals with plasma from any of them
gives rise to the formation of hypertensin. But no hypertensin
is formed when any of those renins is incubated with human
plasma. On the other hand, human renin is active on the plasma
of any of those animals and also on human plasma. This peculiar
specificity of genin led to the prediction that no pressor response
should be obtained in man when pig's renin, for instance,
is injected intravenously, while human renin should be active
(Fasciolo, Leloir, Munioz, and Braun-Menendez, 1940a). This
prediction was verified by experiments (Battro and others,
1940). Bean (1942) found no renin in the kidneys of the
species of fishes and amphibians studied by him. He found
renin in the kidneys of fowl and duck which acted exclusively
on blood belonging to the same class.
Hypertensinogen
Hypertensinogen, the substrate of renin in the reaction which
leads to the formation of hypertensin, can be prepared from
blood plasma or serum by fractional precipitation with
ammonium sulphate or potassium phosphate. It is a globulin,
probably a euglobulin, and is inactivated by heat at 600 C.
Attempts to obtain hypertensinogen from other sources than
blood serum have failed: liver, spleen, thymus, testes, lungs,
heart or skeletal muscle, milk and egg proteins, haemoglobin,
serum albumin, and some vegetable proteins did not yield
hypertensin when incubated with renin (Munioz, Braun-
Menendez, Fasciolo, and Leloir, 1940). Hypertensinogen can
be estimated in blood samples by the maximum amount of
hypertensin it produces. A unit of hypertensinogen is that
which gives rise to one unit of hypertensin under the conditions
outlined.
Hypertensin
This substance, which was discovered in the venous blood
of ischaemic kidneys, is the product of the enzymatic reaction
between renin and hypertensinogen.
In 1938 Kohlstaedt, Helmer, and Page shdwed that purified
preparations of renin produced no vasoconstriction when per-
fused with Ringer's solution through a dog's tail or rabbit's
ear, but that the vasoconstrictor activity could be restored by
the addition of a protein-like substance contained in blood.
They designated this substance renin-activator to connote that
renin was inactive as a vasoconstrictor substance without it.
Subsequently they found (Page and Helmer, 1940) that from
the interaction of these two substances a new substance resulted
with potent vasoconstrictor and pressor actions which they
called " angiotonin." It is interesting how, coming in two different
ways-the Indianapolis group via the purification of renin, and
that of Buenos Aires via isolation of the active substance in
the venous blood of ischaemic kidneys-both groups arrived
independently and simultaneously at the discovery of the sub-
stance which results from the interaction of renin and blood.
Hypertensin is very soluble in water, insoluble in ether,
thermostable, and acid-resistant. In NaOH 0.15 at 1000 C. it
is destroyed in 10 minutes. Kept in the cold store and free
from contamination, hypertensin, dried or in solution, is stable.
It can be salted out by ammonium sulphate. It dialyses through
cellophane. It is inactivated by incubation with pepsin and
trypsin. Although Page and Helmer report that the biuret
reaction is negative, the inactivation by pepsin would indicate
that it is a polypeptide. Some of its chemical and physical
properties (velocity of diffusion) and its proteic origin are
in favour of this idea. We have not been able to obtain a
pure product, and this has compelled us to adopt an arbitrary
unit in order to compare the pressor action of different solu-
tions of hypertensin. A unit of hypertensin is the amount
necessary, when given intravenously, to raise the arterial
pressure of a 10-kg. chloralosed dog an average of 30 mm. Hg.
A standard solution was prepared which has 1 unit per c.cm.
Hypertensin does not cause tachyphylaxis. When the dose
is increased the rises in pressure in mm. Hg increase as the
square root of the units injected, according to the formula
X=St ,y, in which X and St are the blood-pressure increases
in mm. Hg obtained by the unknown and by 1 c.cm. of the
standard solution respectively, and y the units of hypertensin
contained in the unknown (Braun-Menendez, Fasciolo, Leloir,
and Mufnoz, 1940b).
The Pressor Action of Renin
There is strong evidence that the action of renin in vivo
is due to the hypertensin formed by its action on
hypertensinogen:
(1) The perfusion of renin in Ringer's solution through a
vascular system does not produce vasoconstriction; but if mixed
with blood globulins and perfused after short incubation,
marked vasoconstriction results, due to the hypertensin formed.
(2) The prolonged pressor action of injected renin may be
explained by the continuous formation of hypertensin: a simi-
lar pressor effect is produced by the continuous intravenous
infusion of hypertensin. (3) When renin does not form hyper-
tensin in vitro it has no pressor action in vivo. For instance,
pig renin, which does not give rise to hypertensin when in-
cubated with human serum, does not produce a pressure
increase when injected intravenously into human beings.
(4) The pressor action of renin is greater when the concentration
of hypertensinogen in blood is increased (dogs nephrectomized
48 hours previously) and smaller when decreased (adrenal
insufficiency) or exhausted (by repeated injections of renin).
(5) The pharmacological actions of renin and hypertensin are
identical when injected into the animal, and are influenced in
the same way by diverse drugs: no change of action by
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Fourneau 933, cocaine, atropine, ergotamine, etc.; potentiation
by veritol or ephetonine (Braun-Menendez, Fasciolo, Leloir,
and Munioz, 1940b).
The pressor action which renin exerts through the formation
of hypertensin is perhaps not the exclusive mechanism in renal
hypertension. It is very possible that other phenomena play
their part. Perhaps also, after hypertension is initiated by
renin, some changes occur in the body which contribute to
maintain the elevated blood pressure, or vice versa.
Treahnent of Renal Hypertension
The better understanding of the mechanism of renal hyper-
tension may give us some indications as to the possibilities of
a specific treatment. This should aim at (Mufioz, Braun-
Menendez, Fasciolo, and Leloir, 1940): (A) suppressing or
diminishing the secretion of renin; (B) destroying the renin
secreted by the ischaemic kidney or inhibiting its reaction with
blood globulins; (C) diminishing the amount of hyperten-
sinogen; and (D) preventing the action of hypertensin by
increasing the amount or the activity of hypertensinase or by
some other mechanism.
(A) Suppression or Diminution of the Secretion of Renin.-
In Goldblatt dogs, release of the constriction of the renal
artery, removal of the clamp, or nephrectomy results in a drop
to normal of the elevated blood pressure. In man the exis-
tence of hypertension with unilateral renal disease has been
recognized. In many of these cases excision of the diseased
kidney resulted in a return of blood pressure to normal with
disappearance of other symptoms and complications. The
development of collateral circulation in the ischaemic kidneys
of Goldblatt dogs-whether spontaneous or promoted by de-
capsulation and implantation of omentum or spleen-results
in a drop to normal of the elevated blood pressure. The
promotion of collateral circulation has also been attempted
in man by grafts of omentum or muscle in renal tissue with
varying results.
(B) Destroying the Renin secreted by the Ischaemic Kidney.
-It'has been shown, first by Fasciolo (1938) and then by others,
that the normal kidney exerts some sort of protective action
against hypertension of renal origin. Groilman, Williams, and
Harrison (1940) on a basis of indirect evidence believed that
this action was due to an antipressor substance secreted by the
normal kidney. They injected extracts of kidney to hyper-
tensive rats and dogs, and obtained a decline in blood pressure..
These extracts were active even on oral administration. Page
and co-workers (1941) have also prepared different kinds of
extracts of kidney, muscle, and lung which, when injected into
dogs or rats with experimental hypertension, caused the blood
pressure to fall to normal levels. They have obtained the same
results in human beings with malignant hypertension. These
studies are very important and promising, but for the moment
it cannot be stated whether those extracts contain specifit neu-
tralizing or antipressor substances or whether their benefit arises
from the introduction of non-specific foreign elements into the
body. The attempts of Wakerlin and Johnson (1941) to neutralize
the action of renin by immunological means have apparently
been unsuccessful. Schroeder and Adams (1941) reduced the
blood pressure of hypertensive human beings, rats, and dogs by
the injection of tyrosinase. They reported that this enzyme in-
activates renin in vitro in the presence of catechol and hyper-
tensin in the presence of serum. Further evidence is necessary
to judge these results.
(C) Diminution of the Amount of Hypertensinogen.-Very
little, if anything, is known about the exact nature of hyper-
tensinogen, its site of formation, etc. It is- nevertheless
theoretically possible to lower the blood pressure in renal
hypertension by diminishing the amount of hypertensinogen.
For the moment we know of only one way to obtain this result
-that is, by the injection of large amounts of renin.
(D) Increase of the Amount of Hypertensinase.-Serum,
plasma, or red cells, and extracts of many organs (kidney, liver,
spleen, etc.) are active in destroying hypertensin, owing to the
presence of a substance which we have designated " hyperten-
sinase." This substance is destroyed by heating and has a pH
optimum between 7.5 and 8.5. It can therefore be considered
as an enzyme. Its action is not suppressed by anaerobiosis,
cyanide, octyl alcohol, chloroform, thymol, toluol, fluoride,
iodo-acetate, pyrogallol, etc. It is precipitated with ammonium
sulphate between 0.3 and 0.6 saturation. It is inactivated in
20 minutes at 250 C. at pH 3.9. A unit of hypertensinase is
the amount which destroys 0.5 unit of hypertensin in 4 hours
in a volume of 10 c.cm. with an initial concentration of 1 unit
of hypertensin (Fasciolo, Leloir, Mufioz, and Braun-Menendez,
1940b). Fasciolo and others (1940a, 1940b) have studied the
distribution of hypertensinase in saline extracts of different
organs. The highest content was found in the kidney and
intestinal mucosa, the lowest in plasma or serum. Haemolysed
blood cells contain a large amount of hypertensinase. We have
made some preliminary essays injecting kidney and liver extracts
rich in hypertensinase into hypertensive dogs. The results,
though promising, have not been very clear. The fact that
hypertensinase is a most unstable substance renders difficult its
isolation in tissue extracts. These difficulties have hampered
progress in this direction. Page now ascribes the antipressor
action of his renal extracts to the presence in them of
hypertensinase.
Conclusion
We believe that the therapeutic problem of renal hyper-
tension has not yet been solved; but we a're confident that
the solution will be attained by a patient and thorough investi-
gation of the underlying mechanisms which are involved in
the production of renal experimental and human hypertension.
In spite of the enormous progress of the past few years we
still know very little about them. Let us hope that in the
near future research will give medicine a new and powerful
weapon to fight arterial hypertension, this most death-dealing
malady to-day.
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